Exactech Receives Court Confirmation of Restructuring Plan and Approval of Sale to Investor Group

Approval Marks Foundation for Long-Term Growth and Success as a New Company

GAINESVILLE, Fla., Sept. 15, 2025 /PRNewswire/ -- Exactech, a global medical technology leader, today announced Court confirmation of its restructuring plan and approval of the sale of its assets to a new ownership group.

The approved sale enables the company's new owners - which includes Strategic Value Partners, LLC (together with its affiliates, "SVP"), Stellex Capital Management LLC, and Greywolf Capital Management LP - to acquire substantially all of the company's operations and assets. With this milestone, the company begins to move past the restructuring process, with customary closing steps for the sale to be completed over the coming weeks.

Following the close of the transaction, the new company will be strategically positioned to execute its mission to be the leading surgeon partner in orthopedics. Along with its team of dedicated employees, proven product lines such as the Equinoxe^® Shoulder; Vantage Ankle^®; Alteon^® and Spartan Hip; Truliant^®, Triverse^® and Newton^® Knee; and GPS navigation will transfer to the new company, as well as engineering and manufacturing expertise and product data gathered over 40 years.

"We are excited to work together to focus on the new company's quality imperative, its commitment to innovation, and its goal of being the most trusted partner to orthopedic surgeons," said Clara Anderson, SVP Managing Director. "Our team will continue to invest in the new company and accelerate opportunities to drive innovation and growth in order to give patients greater mobility and empower surgeons with the products, technologies and support they need to be successful."

The new company will be led by its incoming Chief Executive Officer, Aurelio Sahagun, as well as a Board of Directors that will provide oversight of the new company's strategy and governance.

About Exactech
Exactech is a global medical technology leader that empowers orthopaedic surgeons with innovative implants, surgical instruments and the Active Intelligence^® (AI) ecosystem of smart technologies to give patients EXACTLY what they need to regain mobility. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and X. For more information, visit www.exac.com.

About SVP
SVP is a global alternative investment firm that focuses on special situations, private equity, opportunistic credit and financing opportunities. The firm uses a combination of sourcing, financial and operational expertise to unlock value in its portfolio companies. Today SVP manages approximately $22 billion in assets under management, and since inception, has invested more than $53 billion of capital. The firm, established by Victor Khosla in 2001, has over 200 employees, including more than 100 investment professionals, across its main offices in Greenwich (CT) and London, and a presence in Tokyo. Learn more at www.svpglobal.com.

About Stellex Capital Management, LLC
With offices in New York, Pittsburgh, Detroit, and London, Stellex Capital is a private equity firm with over $3.9 billion in assets under management. Stellex seeks to identify and deploy capital in opportunities that stand to benefit from its operationally focused and hands-on approach to investing. Portfolio companies are supported by Stellex's industry knowledge, operating capabilities, network of senior executives, strategic insights, and access to capital.

About Greywolf LP
Founded in 2003, Greywolf Capital Management LP ("Greywolf" or the "Firm") is a registered investment adviser with over $3 billion in assets under management allocated across our Distressed/Special Situations, CLO Credit and Hard Asset Strategies. Our accomplished and cohesive team of 32 includes 14 dedicated investment professionals. At Greywolf, we combine the expertise developed over our history with time-tested portfolio management skills to offer attractive, risk-adjusted returns over the long-term with little correlation to the broad based markets. The Firm has earned a reputation for its commitment to integrity, transparency and alignment as a true partner with our investors.

SOURCE Exactech, Inc